AWAnnemarie Wasley

Annemarie Wasley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annemarie Wasley has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hepatitis A Virus

    by Annemarie Wasley, Stephen M. Feinstone, Beth P. Bell


  • Open Access

    Hepatitis A in the Era of Vaccination

    by Annemarie Wasley, Anthony Fiore, Beth P. Bell

    The World Health Organization estimates an annual total of 1.5 million clinical cases of hepatitis A worldwide, but seroprevalence data indicate that tens of millions of hepatitis A virus infections occur each year. In the United States in the 1980s–1990s, an average of 26,000 acute hepatitis A cases were reported per year, representing approximately 270,000 infections annually. Since licensure of effective hepatitis A vaccines in the mid-1990s, US hepatitis A rates have fallen precipitously—particularly since 1999, when routine childhood vaccination was recommended in states with consistently elevated rates. By 2004, the overall rate had declined to 1.9/100,000 population, the lowest rate ever recorded and 79% lower than any previously recorded nadir. These marked declines occurred with relatively modest vaccination coverage, suggesting that strong herd immunity accompanies the initiation of routine vaccination programs. Routine childhood vaccination has produced similar results in Israel and selected regions of Italy, Spain, and Australia. Hepatitis A vaccination will probably remain a low priority for some time in the poorest countries, where most persons are infected as young children. However, shifts in the epidemiologic patterns of disease associated with declining hepatitis A virus transmission are occurring in many regions of the world. These shifts are likely to create circumstances where strategically targeted vaccination of children could produce substantial public health benefits.


  • Declining Incidence of Hepatitis A—Reply

    by Annemarie Wasley, Beth Bell

    In Reply: In the United States, the dramatic declines in the incidence of hepatitis A among children and their close contacts have resulted in changes in the epidemiologic profile of this disease, including a shift in the distribution of cases by age, race, and region, as well as changes in the frequency of potential sources of infection as reported in national surveillance data. The large community-wide outbreaks that were driven by infections among children and transmission within households and extended family settings, previously accounting for the majority of cases in the United States, have become rare. A declining proportion of cases report sexual or household contact with another case or potential exposure through attendance in child day care.1 As sources of local, community-based transmission have been reduced, an increasing proportion of the cases that continue to occur are in high-risk groups such as international travelers.

  • Incidence of Hepatitis A in the United States in the Era of Vaccination

    by Annemarie Wasley, Taraz Samandari, Beth P. Bell

    Research from JAMA — Incidence of Hepatitis A in the United States in the Era of Vaccination — ContextIn the United States, hepatitis A is a frequently reported vaccine-preventable disease. Vaccination has been recommended for persons at increased risk since 1996. In 1999, it was recommended that children living in 11 states with the highest incidence of hepatitis A be routinely vaccinated, and that children living in 6 additional states, with incidence above the national average, be considered for routine vaccination.ObjectiveTo assess impact of the current vaccination strategy by evaluating trends in reported cases of hepatitis A since implementation.Design, Setting, and CasesA longitudinal analysis of characteristics of cases of hepatitis A reported in the United States since 1990 to the National Notifiable Diseases Surveillance System.Main Outcome MeasureIncidence rates of reported cases of hepatitis A. Incidence rates in 2003 were compared with those for the prevaccination baseline period (1990-1997) overall and in the 17 states in which children should be routinely vaccinated or considered for routine vaccination (vaccinating states). Incidence rates in vaccinating states were also compared with those in the remaining states where there is no recommendation for statewide vaccination of children (nonvaccinating states).ResultsBetween the baseline period (1990-1997) and 2003, overall hepatitis A rates declined 76% to 2.6 per 100 000, significantly lower than previous nadirs in 1983 (9.2/100 000) and 1992 (9.1/100 000). The rate in vaccinating states declined 88% to 2.5 per 100 000 compared with 53% elsewhere (to 2.7/100 000). In 2003, cases from vaccinating states accounted for 33% of the national total vs 65% during the baseline period. Declines were greater among children aged 2 to 18 years (87%) than among persons older than age 18 years (69%); the proportion of cases in children dropped from 35% to 19%. Since 2001, rates in adults have been higher than among children, with the highest rates now among men aged 25 through 39 years.ConclusionsFollowing implementation of routine hepatitis A vaccination of children, hepatitis A rates have declined to historic lows, accompanied by substantial changes in the epidemiologic profile. Greater decreases in the age groups and regions where routine vaccination of children is recommended likely reflect the results of implementation of this novel vaccination strategy. Continued monitoring is needed to verify that implementation continues to proceed and that low rates are sustained.